Estrada Mena, Francisco Javier

Main Affiliation

Facultad de Ciencias de la Salud - CampCM

Preferred name

Official Name

Estrada Mena, Francisco Javier

ORCID

0000-0002-0833-3630

Researcher ID

AAI-2437-2020

Scopus Author ID

57192982524

Now showing 1 - 10 of 32

Some of the metrics are blocked by your
consent settings
Novel genome-wide associations for age-related macular degeneration in the sarcoglycan-sarcospan protein complex
(2020)
Asaf Calderon, Andrea Michelle
;
Dewan, Andrew
;
Ramírez, Israel
;
Zepeda-Palacio, Claudia
;
Palacio, Claudia
Purpose : Since the advent of genomic approaches, many chromosomal regions and polymorphisms have been associated with age-related macular degeneration (AMD). However, most of the disease variability might not be still captured by current researched genetic markers due to power issues. We have evidence that at least one component of the sarcoglycan-sarcospan protein complex (Sg-Sspn) gene is associated with increased odds of geographic atrophy (GA) AMD. Moreover, the retina of the knocked-out mouse model for the Sg-Sspn phenotypically resembles GA. Here, we aimed to explore the genome-wide association of the Sg-Sspn complex gene regions with AMD.
2 19
Some of the metrics are blocked by your
consent settings
Preparation of Mouse Embryonic Eye Sections for Routine Histology
(Springer US, 2026)
Lira-Romero, Esmeralda
;
Estrada Mena, Francisco Javier
;
Ramírez-Sánchez, Israel
7
Some of the metrics are blocked by your
consent settings
Development of muscle atrophy and loss of function in a Gulf-War illness model: underlying mechanisms
(2020)
Ramírez-Sánchez, Israel
;
Navarrete-Yañez, Viridiana
;
Garate-Carrillo, Alejandra
;
Loredo Mendoza, María Lilia
;
Lira, Esmeralda
Gulf War illness (GWI) afflicts military personnel who served during the Persian Gulf War and is notable for cognitive deficits, depression, muscle pain, weakness, intolerance to exercise, and fatigue. Suspect causal agents include the chemicals pyridostigmine (PB), permetrim (PM) and N,N-diethyl-m-toluamide (DEET) used as protectants against insects and nerve gases. No pre-clinical studies have explored the effects on skeletal muscle (SkM). Young male rats were provided PB, PM and DEET at equivalent human doses and physical restraint (to induce stress) for 3 weeks followed a 3-week recovery. GWI gastrocnemius weight was ~ 35% lower versus controls, which correlated with decreases in myofiber area, limb strength, and treadmill time/distance. In GWI rats, SkM fiber type relative abundance changed towards slow type I. Muscle wasting pathway proteins were upregulated while those that promote growth decreased as did mitochondrial endpoints and muscle ATP levels. Proteomic analysis of SkM also documented unique alterations in mitochondrial and metabolic pathways. Thus, exposure to GWI chemicals/stress adversely impacts key metabolic pathways leading to muscle atrophy and loss of function. These changes may account for GWI Veterans symptoms.
1Scopus© Citations 11 11
Some of the metrics are blocked by your
consent settings
nef/long terminal repeat quasispecies from HIV type 1-infected Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID mice
(2000)
Gómez-Román, Víctor Raúl
;
Vásquez, Joel A.
;
Basualdo, Maria Del Carmen
;
Estrada Mena, Francisco Javier
;
Soler, Carmen
To examine the genetic features of the long terminal repeat (LTR) derived from six HIV-1-infected individuals enrolled in the Mexico City Cohort, we cloned and sequenced a 505-bp fragment of the proviral LTR from their peripheral blood mononuclear cells (PBMCs). All patients harbored HIV-1 LTR quasispecies corresponding to the B subtype. Three patients with high CD4+ T cell counts (>500/mm3) presented LTR sequences with point mutations in the TAR bulge. The LTR sequence from a patient classified as a long-term nonprogressor (LTNP) presented the most frequent naturally occurring length polymorphism (MFNLP) and two substitutions in the TAR region that were predicted to result in two alternative secondary RNA structures. A novel 18-bp deletion, which eliminates part of the putative binding site for the nuclear factor of activated T cells (NFAT-1), was identified in the overlapping nef/LTR sequence derived from a patient progressing to AIDS. This deletion coincides with the ability of this virus to consistently replicate at low levels in vivo (viral load <500 RNA copies/ml) and in vitro (unsuccessful virus isolation). On one occasion, when virus isolation was successful, the 18-bp deletion was no longer evident and LTR sequences with intact NFAT-1-binding sites were observed. Inoculation of hu-PBL-SCID mice with viruses from several Mexican patients resulted in differential CD4+ T cell depletion patterns 15 days postinfection, which agree with the in vivo CD4+ T cell count data from each patient. © AIDS Research and Human Retroviruses
Scopus© Citations 11 2 12
Some of the metrics are blocked by your
consent settings
Mejoras en el diagnóstico de distrofinopatías: ¿qué hemos aprendido después de 20 años?
(Viguera Editores, 2011)
López Hernández, Luz Berenice
;
Ayala Madrigal, María de la Luz
;
Heusden, Dave van
;
Estrada Mena, Francisco Javier
;
Canto Cetina, Ileana Patricia
Introducción: Las distrofinopatías son trastornos genéticos ligados al cromosoma X causados por mutaciones en el gen DMD. Las pruebas genéticas son de suma importancia para la gestión y el asesoramiento genético de estas enfermedades. Sin embargo, la complejidad del gen DMD es un desafío para el diagnóstico. Objetivo: Describir los avances recientes en el diagnóstico de distrofinopatías, después de 20 años de los primeros ensayos moleculares para la detección genética de estas enfermedades. Desarrollo: En la actualidad, se han desarrollado una variedad de estrategias, como la detección de mutaciones automatizada, los métodos basados en células y la haplotipificación de alto rendimiento, para facilitar el diagnóstico de distrofinopatías, la detección de portadoras, el diagnóstico prenatal y preimplantacional. ©Viguera Editores
2 23Scopus© Citations 7
Some of the metrics are blocked by your
consent settings
Machine learning method to establish the connection between age related macular degeneration and some genetic variations
(2016)
Martínez Velasco, Antonieta Teodora
;
Zenteno, Juan Carlos
;
Martinez-Villaseñor, Lourdes
;
Miralles-Pechuán, Luis
;
Estrada Mena, Francisco Javier
Medicine research based in machine learning methods allows the improvement of diagnosis in complex diseases. Age related Macular Degeneration (AMD) is one of them. AMD is the leading cause of blindness in the world. It causes the 8.7% of blind people. A set of case and controls study could be developed by machine-learning methods to find the relation between Single Nucleotide Polymorphisms (SNPs) SNP_A, SNP_B, SNP_C and AMD. In this paper we present a machine-learning based analysis to determine the relation of three single nucleotide SNPs and the AMD disease. The SNPs SNP_B, SNP_C remained in the top four relevant features with ophthalmologic surgeries and bilateral cataract. We aim also to determine the best set of features for the classification process. © Springer International Publishing AG 2016.
2 16Scopus© Citations 2
Some of the metrics are blocked by your
consent settings
A new de novo mutation in a non-hot spot region at the DMD gene in a Mexican family
(2015)
Luna-Angulo, A. B.
;
Gómez-Díaz, B.
;
Escobar-Cedillo, R. E.
;
Anaya-Segura, M. A.
;
Estrada Mena, Francisco Javier
In this report we present the analysis of a sporadic case of DMD and his family. In the present case, a deletion of exons 18-47 is presented which predicts abolition of the reading frame and is located between the well-known deletion hot spots of the DMD gene. This mutation was not previously reported in the Leiden database (LOVD). Both MLPA and segregation analysis with short tandem repeat markers elucidated the status of the mother, sister and the younger brother of the proband, who were not carriers of the mutation. This case provides a description of a new pathogenic variant presented as de novo mutation in a DMD patient. Haplotype analysis and complete gene screening may improve genetic counseling in cases of germline mosaicism and de novo mutations.
1 16
Some of the metrics are blocked by your
consent settings
Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins
(2024)
Alexandra Luna-Angulo
;
Carlos Landa-Solís
;
Rosa Elena Escobar-Cedillo
;
Estrada Mena, Francisco Javier
;
Laura Sánchez-Chapul
<jats:p>Muscular dystrophies (MDs) are a heterogeneous group of diseases of genetic origin characterized by progressive skeletal muscle degeneration and weakness. There are several types of MDs, varying in terms of age of onset, severity, and pattern of the affected muscles. However, all of them worsen over time, and many patients will eventually lose their ability to walk. In addition to skeletal muscle effects, patients with MDs may present cardiac and respiratory disorders, generating complications that could lead to death. Interdisciplinary management is required to improve the surveillance and quality of life of patients with an MD. At present, pharmacological therapy is only available for Duchene muscular dystrophy (DMD)—the most common type of MD—and is mainly based on the use of corticosteroids. Other MDs caused by alterations in dystrophin-associated proteins (DAPs) are less frequent but represent an important group within these diseases. Pharmacological alternatives with clinical potential in patients with MDs and other proteins associated with dystrophin have been scarcely explored. This review focuses on drugs and molecules that have shown beneficial effects, mainly in experimental models involving alterations in DAPs. The mechanisms associated with the effects leading to promising results regarding the recovery or maintenance of muscle strength and reduction in fibrosis in the less-common MDs (i.e., with respect to DMD) are explored, and other therapeutic targets that could contribute to maintaining the homeostasis of muscle fibers, involving different pathways, such as calcium regulation, hypertrophy, and maintenance of satellite cell function, are also examined. It is possible that some of the drugs explored here could be used to affordably improve the muscular function of patients until a definitive treatment for MDs is developed.</jats:p>
16Scopus© Citations 2
Some of the metrics are blocked by your
consent settings
Influence of GST polymorphisms in the age of onset of cataract: Systematic review and meta-analysis
(2020)
Antonio-Aguirre, Bani
;
Palacio Pastrana, Claudia
;
Mendoza Velásquez, Cristina
;
Camacho-Ordóñez, Azyadeh
;
Zepeda-Palacio, Claudia
Purpose : Cataracts are a clinically heterogeneous disorder affecting up to 12% of the population aged 40 years and older. Multiple environmental and genetic factors influence disease susceptibility. Glutathione S-transferase (GST) genes deletion might be involved in cataractogenesis, through impaired conjugation of reduced glutathione. Excessive ROS could promote earlier lens opacification. To date, no systematic studies have assessed the effect of GST polymorphisms and age of onset of cataracts. Here, we aim to evaluate the association between GST polymorphisms, found through a systematic review, on cataracts age of presentation by meta-analysis. Methods : We conducted a systematic search in MEDLINE, HuGENET, and LILACS databases. We included observational studies that determined genotype based on validated genotyping instruments and with a stringent quality check (e.g., genotyping call rate ≥ 95%, HWE in controls). We abstracted counts of null alleles of GSTM1 and GSTT1 in cases and controls. We performed a meta-analysis of these measurements using random and fixed effects models, subgrouping by age of diagnosis. ©Investigative Ophthalmology & Visual Science
2 7
Some of the metrics are blocked by your
consent settings
Effects of (−)-epicatechin on frontal cortex DAPC and dysbindin of the mdx mice
(2017)
Estrada Mena, Francisco Javier
;
Rodríguez, Alonso
;
Mendoza-Lorenzo, Patricia
;
Neri-Gómez, Teresa
;
Rodríguez, Sergio
Introduction: Multiple components of the dystrophin-associated protein complex (DAPC) are expressed in numerous tissues including the brain. Members of the DAPC and dysbindin are abnormally expressed in the brain of Duchenne Muscular Dystrophy (DMD) patients, which has been associated with cognitive impairments. However, little is known about the expression pattern of individual members of the DAPC in animal models of DMD and their relationship with dysbindin. Methods: Ten mdx mice were randomly allocated into a control and intervention group [(−)-epicatechin (Epi) 1 mg/kg/day for four weeks] and results compared to a wild-type mice. After sacrifice, brain pre-frontal cortices were collected for Western blotting and immunoprecipitation assays, and sagittal sections processed for immunohistochemistry.
Scopus© Citations 3 2 7

Estrada Mena, Francisco Javier

Filters

Settings

Sort By

Results per page